Skip to content

Vaxcyte, Inc. PCVX Other Non-Current Assets

Other Non-Current Assets at other companies

Moderna logo
ModernaMRNA
$50M+213%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$300K+37.6%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×
Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s other non-current assets?
Vaxcyte, Inc. (PCVX) reported other non-current assets of $155.54M in Q1 2026.
How has Vaxcyte, Inc.'s other non-current assets changed year-over-year?
Vaxcyte, Inc.'s other non-current assets increased by 103.9% year-over-year, from $76.28M to $155.54M.
What is the long-term trend for Vaxcyte, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s other non-current assets has grown at a 193.0% compound annual growth rate (CAGR), from $550K to $118.85M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.